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Abstract
Background: Leiomyosarcomas typically originate within smooth muscle cells. Leiomyosarcomas
arising from the adrenal vein are rare malignancies associated with delayed diagnosis and poor
prognosis. The most common vascular site of origin is the inferior vena cava.
Case presentation: This is a 64-year old woman who presented with a 13 × 6.5 × 6.6 cm
heterogeneous mass arising in the region of the right adrenal gland and extending into the inferior
vena cava (IVC) and the right atrium. Biochemical evaluation excluded a functional tumor of the
adrenal gland, and multiple tumor markers were negative. We present the novel use of deep
hypothermic circulatory arrest (DHCA) in the resection of an adrenal vein leiomyosarcoma
extending into the right atrium. The patient remains free of disease ten months after surgery.
DHCA afforded a bloodless operative field for optimal resection of disease from within the IVC.
Conclusion: The diagnosis of leiomyosarcomas of the adrenal vein is one of exclusion and involves
preoperative radiological imaging and biochemical evaluation to exclude other functional tumors of
the adrenal gland. Aggressive surgical resection is associated with improved survival and may be
best achieved via collaboration among different surgical subspecialties.
Background
Leiomyosarcoma is a soft-tissue tumor that differentiates
from smooth muscle. Primary leiomyosarcomas of vascu-
lar origin are relatively rare and frequently arise within the
IVC [1-3]. Rarely, leiomyosarcomas may arise from the
renal or adrenal vein. We report the case of a leiomyosar-
coma of the adrenal vein and a novel approach to surgical
resection involving the use of deep hypothermic circula-
tory arrest (DHCA).
Case presentation
A 64-year old woman who presented with a 9-month his-
tory of persistent, non-productive cough, bilateral lower
extremity edema, and multiple spider angiomata extend-
ing from umbilicus to ankles. The patient was otherwise
healthy with no significant past medical, surgical, or fam-
ily history. She denied recent weight loss, fevers, chills,
nausea, vomiting, abdominal or back pain, and she had
no difficulty with ambulation. Physical exam also was sig-
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nificant for hepatomegaly extending 4 fingerbreadths
below the costal margin. There was no jaundice or virili-
zation. Routine laboratory studies were unremarkable.
Computed tomography (CT) scan revealed a 13 × 6.5 ×
6.6 cm heterogeneous mass arising in the region of the
right adrenal gland and extending into the IVC and the
right atrium (Figure 1).
CT of the chest and magnetic resonance imaging with arte-
rial and venous phases (MRA/MRV) revealed evidence of
a filling defect within the most inferior portion of the right
atrium at the confluence with the IVC. Twenty-four hour
urine collections for cortisol and catecholamines were
normal, as were serum aldosterone, renin, potassium, and
ACTH levels. Multiple tumor markers also were normal,
including dehydropepiandrosterone sulfate (DHEA-S),
lactate dehydrogenase (LDH), carcinomembryonic anti-
gen (CEA), alpha-feto protein (AFP), CA-125, and CA-19-
9; only an elevated CA-125 was identified (130, normal <
35 U/mL). There was no evidence of metastases on chest
CT, brain MRI, and bone scan.
The differential diagnosis included adrenocortical carci-
noma, renal cell carcinoma, retroperitoneal sarcoma, or
hepatoma. The patient was brought to the operating room
for a planned adrenalectomy, possible right nephrectomy,
cholecystectomy (for cholelithiasis), and tumor resection
via IVC cavotomy under DHCA. Diagnostic laparoscopy
revealed no evidence of peritoneal or hepatic metastases.
Exploratory laparotomy was performed through a midline
incision, followed by a Köcher maneuver. The adrenal
lesion was noted to be separate from the right kidney.
Intraoperative ultrasound confirmed that the tumor did
not involve the caudate lobe of the liver.
A median sternotomy was performed, and the diaphragm
was divided in the midline anteriorly. The adrenal gland
was mobilized from the liver, and the IVC was fully
exposed. The patient was then placed on cardiopulmo-
nary bypass with DHCA, and her core body temperature
was lowered to 19°C. The IVC was incised, and intramural
tumor was dissected free from the walls of the IVC and
excised en bloc with the adrenal gland (Figure 2). There
was no evidence of residual disease within the IVC or right
atrium on transesophageal echocardiogram (TEE). After
completion of the IVC cavotomy, the patient was taken off
DHCA and re-warmed. Total circulatory arrest time was
14 minutes, with a bypass time of 115 minutes. The aorta
was cross-clamped for 25 minutes. She required 6 units of
packed red blood cells, 4 units of fresh frozen plasma, 4
units of platelets, and 5 liters of crystalloid. The total pro-
cedure time was 7 1/2 hours.
The patient required pharmacologic cardiovascular sup-
port for the first 12 hours postoperatively, but was awake
within 24 hours. She was extubated on the morning of
first postoperated day and displayed no neurocognitive
deficit. The balance of her postoperative course was com-
plicated by the development of a symptomatic pulmonary
embolus, diagnosed by spiral CT of the chest. An ultra-
sound of the IVC also was performed to exclude tumor
embolus; no evidence of thrombus was seen. She was dis-
charged on 12th postoperative day on oral anticoagula-
tion. Pursuant PET-CT showed no evidence of uptake in
the lungs, providing further confirmation that this was a
pulmonary embolus, and not tumor thrombus.
Intraoperative resection of tumor (A) from adrenal vein and  IVC (B) Figure 2
Intraoperative resection of tumor (A) from adrenal vein and 
IVC (B).
Sagittal view of abdominal MRI Figure 1
Sagittal view of abdominal MRI. Tumor (arrow) extends from 
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On pathological examination, the specimen measured
14.2 × 9.5 × 5.5 cm. Cross-sections of the tumor revealed
a firm, nodular and trabeculated tan-white mass with
focal areas of cystic degeneration and hemorrhage (Figure
3). The tumor was surrounded by a thin rim of fibrous tis-
sue and abutted, but did not penetrate, grossly identifia-
ble adrenal gland (Figure 4A). On microscopic evaluation,
the tumor was markedly cellular, composed of spindle
cells arranged in intersecting fascicles. Tumor cells showed
moderate atypia with hyperchromasia, nuclear enlarge-
ment and occasional giant cells. Three to five mitoses per
10 high power field were identified, with occasional atyp-
ical mitotic figures (Figure 5). Areas of coagulative necro-
sis were present. Immunohistochemically, neoplastic cells
were negative for c-kit, S100 and HMB45 (Dako®), but
showed strong reactivity for desmin and smooth muscle
actin (Dako®) (Figure 4C). This finding was consistent
with leiomyosarcoma, most likely arising from adrenal
vein; however, on multiple sections, no residual vascular
wall was detected. Primary adrenal leiomyosarcoma was
considered unlikely due to clear-cut separation of tumor
from the morphologically unremarkable adrenal gland by
a thin rim of fibrous tissue (Figure 4A).
Discussion
A leiomyosarcoma of the adrenal vein was first reported in
1981, in a 50-year old patient with a 12 cm leiomyosar-
coma arising from the left adrenal vein [4]. Since that
time, there have been only eight other reported cases. We
report a ninth case, using the novel approach of surgical
resection under DHCA.
The preoperative diagnosis of a leiomyosarcoma was not
established in any of the previously reported cases. How-
ever, while the exact etiology of an adrenal tumor may not
be known, biochemical evaluation is warranted to exclude
a functional tumor that may require preoperative medical
management, i.e. alpha blockade. Excluding two histori-
cal cases identified at the time of autopsy, all tumors were
≥ 10 cm and diagnosed at the time of surgical resection,
underscoring that there are no tumor markers or imaging
characteristics specific to this diagnosis [3-10]. Outcome
from leiomyosarcoma is poor; the longest disease-free sur-
vival is 20 months [5]. Four patients died within a year of
The higher power image shows spindle tumor cells with  mitotic activity (arrow) Figure 5
The higher power image shows spindle tumor cells with 
mitotic activity (arrow).
Gross specimen shows a well-circumscribed, partially encap- sulated solid tumor with areas of necrosis and hemorrhage Figure 3
Gross specimen shows a well-circumscribed, partially encap-
sulated solid tumor with areas of necrosis and hemorrhage. 
Arrow points to normal adrenal gland.
Tumor (A) shows a rim of fibrous tissue (B) separating it  from adjacent adrenal cortex (C) Figure 4
Tumor (A) shows a rim of fibrous tissue (B) separating it 
from adjacent adrenal cortex (C).World Journal of Surgical Oncology 2007, 5:109 http://www.wjso.com/content/5/1/109
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surgery [3,7,8,10]. Our patient is currently clinically free
of disease ten months after resection.
Complete surgical resection is the mainstay of treatment
for adrenal vein leiomyosarcomas, as there is little evi-
dence to support the role of chemotherapy and/or radia-
tion. Lack et al reported the use of combination
chemotherapy (including adriamycin) and external beam
radiation to palliate bone pain in a patient with metastatic
disease arising from an adrenal vein leiomyosarcoma [3].
Patient survival has been limited to 6 months following
treatment with a combination of vincristine/cyclophos-
phamide/cisplatin/dacarbazine or external beam radia-
tion [7,10].
Leiomyosarcoma of the adrenal vein can extend into the
IVC or the right atrium [8,10]. In a report by Matsui et al,
a 10 × 9 × 5 cm mass extending from between the left kid-
ney and adrenal gland to the IVC was resected via a left
radical nephrectomy-adrenalectomy with IVC thrombec-
tomy [8]. Kato et al reported a right adrenal leiomyosar-
coma that extended via IVC into right atrium. Tumor
resection, including adrenalectomy, nephrectomy, IVC
thrombectomy, and pulmonary artery thrombectomy,
was approached via a midline abdominal incision,
median sternotomy, and cardiopulmonary bypass [10].
To our knowledge, this is the first reported case of the use
of DHCA for the resection of an adrenal vein leiomyosar-
coma. The use of DHCA for resection of other retroperito-
neal tumors, including renal cell carcinomas and
adrenocortical carcinomas, has previously been reported
[11-13]. Total circulatory arrest is only required for the
critical period of tumor removal from the IVC and right
atrium. Neurological sequelae of DHCA can be transient
(i.e. post-operative confusion, delirium and agitation) or
permanent, secondary to postoperative stroke and result-
ing in gross dysfunction; the upper limit of DHCA for
brain protection is 40 minutes [14]. Our patient did not
immediately exhibit any of these symptoms, but she
developed minor disturbances in gait and difficulty with
slurring of her speech six weeks postoperative. It is unclear
if DHCA was related to her symptoms; CT and MRI of the
head were unremarkable.
A comprehensive review of the medical literature reveals
that the predominant subtype of leiomyosarcoma arises
within the IVC. Still, there have been fewer than 300
reported cases since the first description by Pearl in 1871.
In 1992, the International Registry of Inferior Vena Cava
Leiomyosarcomas was instituted, with 218 registered
patients [15]. Leiomyosarcomas may arise anywhere
within the IVC. Tumor arises within the smooth muscle of
the media of the IVC, and initially grows in an intramural
fashion, though it ultimately extends either intralumi-
nally and/or extraluminally. Aggressive surgical resection
is the standard treatment for leiomyosarcomas of vascular
origin and is associated with improved survival [2,16,17].
Overall, adjuvant treatment appears to afford no addi-
tional benefit [16,17].
Conclusion
First-line treatment for leiomyosarcomas of the adrenal
vein is radical resection with the goal of negative margins.
Preoperative evaluation should include imaging to delin-
eate the extent of disease and exclude metastases and bio-
chemical evaluation to rule out catecholamine excess
from a functional adrenocortical carcinoma or malignant
pheochromocytoma requiring preoperative alpha-block-
ade.  Collaboration among multiple surgical subspecial-
ties might be beneficial, and the novel role of DHCA
described here should be considered in the surgical man-
agement of these tumors.
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